首页>
外国专利>
ANTI-INFLAMMATORY NON-SIALYLATED POLYPEPTIDE OF A MODIFIED hIgG1 Fc REGION, METHOD OF MAKING SAME AND USE THEREOF
ANTI-INFLAMMATORY NON-SIALYLATED POLYPEPTIDE OF A MODIFIED hIgG1 Fc REGION, METHOD OF MAKING SAME AND USE THEREOF
展开▼
机译:修饰的hIgG1 Fc区域的抗炎性非唾液酸化多肽,其制备方法及其用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to an isolated polypeptide comprising a modified sequence that is free of sialylation and is at least 75% identical to an hIgG1 Fc region sequence which is SEQ ID NO: 1 and is replaced with alanine or a conservative amino acid in position corresponding to an F241 sequence SEQ ID NO: 1 in accordance with Kabat numbering system, wherein the polypeptide has an anti-inflammatory activity that is higher than that of a parent polypeptide comprising SEQ ID NO: 1. The present invention also relates to a method for making the claimed polypeptide, an anti-inflammatory composition comprising the claimed polypeptide, a method for treating an inflammatory disease comprising administering to a subject in need thereof a therapeutically effective amount of the claimed polypeptide.
展开▼
机译:本发明涉及分离的多肽,其包含修饰序列,该修饰序列没有唾液酸化并且与SEQ ID NO:1的hIgG1 Fc区序列具有至少75%的同一性,并在对应的位置被丙氨酸或保守氨基酸取代根据Kabat编号系统对F241序列SEQ ID NO:1进行修饰,其中该多肽的抗炎活性高于包含SEQ ID NO:1的亲本多肽的抗炎活性。本发明还涉及用于制备要求保护的多肽,包含要求保护的多肽的抗炎组合物,治疗炎性疾病的方法,其包括向有需要的受试者施用治疗有效量的要求保护的多肽。
展开▼